China, Unhampered by Rules, Races Ahead in Gene-Editing Trials

U.S. scientists helped devise the Crispr biotechnology tool that has captured global attention for its potential to treat incurable diseases. The first to test it in humans are Chinese doctors, who don?t face the same regulatory hurdles as American counterparts.

https://www.wsj.com/articles/china-unhampered-by-rules-races-ahead-in-gene-editing-trials-1516562360

About Robert Zinn

Robert Zinn, M.D., Ph.D. is a medical doctor, physician, and web entrepreneur, who, for over 15 years was employed by academic and research institutions and focused his clinical practices on very specialized patient populations, such as those with rare genetic diseases or rare cancers. He shares his knowledge through his website, NutritionTheory.org

View all posts by Robert Zinn →